Cargando…
Changes in Serum Nesfatin-1 After Laparoscopic Sleeve Gastrectomy are Associated with Improvements in Nonalcoholic Fatty Liver Disease
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is a serious and widespread disease worldwide. Bariatric surgery is one of the treatments for NAFLD. Nesfatin-1 is located in the brain, periphery and plasma. We studied the relationship between nesfatin-1 changes after laparoscopic sleeve gastrec...
Autores principales: | Yang, Keyu, Zhang, Xiaowei, Zhou, Yong, Chen, Fu, Shen, Mingyang, Wang, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200260/ https://www.ncbi.nlm.nih.gov/pubmed/32431529 http://dx.doi.org/10.2147/DMSO.S246281 |
Ejemplares similares
-
MiR-200c-3p Regulates DUSP1/MAPK Pathway in the Nonalcoholic Fatty Liver After Laparoscopic Sleeve Gastrectomy
por: Zhang, Tao-tao, et al.
Publicado: (2022) -
Laparoscopic sleeve gastrectomy alters (1)H-NMR-measured lipoprotein and glycoprotein profile in patients with severe obesity and nonalcoholic fatty liver disease
por: Cabré, Noemí, et al.
Publicado: (2021) -
Pyogenic liver abscess after laparoscopic sleeve gastrectomy
por: Demir, Hakan, et al.
Publicado: (2018) -
Improvement of non‐alcoholic fatty liver disease after laparoscopic sleeve gastrectomy in Japanese obese patients
por: Endo, Yuichi, et al.
Publicado: (2019) -
Changes in bowel habits after laparoscopic sleeve gastrectomy
por: Ostruszka, Petr, et al.
Publicado: (2019)